Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
NCT00709098
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
iloprost
DRUG:
iloprost
Sponsor
Actelion